12 Month Price Forecast For EQS
Distance to EQS Price Forecasts
EQS Price Momentum
🤔 Considering Equus Total Return (EQS)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 6, 2025 2:33 PM UTC
EQS Analyst Ratings & Price Targets
Currently, there are no Wall Street analyst price targets or forecasts available for EQS (Equus Total Return).
EQS is currently trading at $1.32. Without active analyst coverage, investors should conduct thorough independent research and consider multiple data points beyond price targets when evaluating this stock for their portfolio.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
EQS Analyst Consensus
EQS Price Target Range
Latest EQS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for EQS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Stocks Similar to Equus Total Return Inc
The following stocks are similar to Equus Total Return based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Equus Total Return Inc (EQS) Financial Data
Equus Total Return Inc has a market capitalization of $17.93M with a P/E ratio of 1.7x. The company generates $845,000 in trailing twelve-month revenue with a 1,140.8% profit margin.
Revenue growth is +2,658.3% quarter-over-quarter, while maintaining an operating margin of -255.6% and return on equity of +21.5%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Equus Total Return Inc (EQS) Company Overview
About Equus Total Return Inc
Specializes in investments in small to mid-sized companies.
The company operates as a business development company (BDC), making money by investing in a variety of financial instruments including equity, debt, and preferred stock in small to mid-sized companies. It targets investments typically ranging from $1 million to $25 million in companies with revenues between $5 million and $150 million, and EBITDA between $2 million to $50 million. By acting as a lead investor, it focuses on leveraged buyouts, management buyouts, and operational turnarounds, among other strategies.
Equus Total Return, Inc. was founded in 1991 and is headquartered in Houston, Texas, with an additional office in Vancouver, Canada. The company invests across various sectors, including technology, healthcare, and alternative energy, and operates in the United States, China, India, and Europe.
Company Information
Sector
Financial Services
Industry
Asset Management
Employees
0
CEO
Mr. John A. Hardy
Country
United States
IPO Year
1992
Website
www.equuscap.comEquus Total Return Inc (EQS) Latest News & Analysis
Equus Total Return, Inc. has appointed Fraser Atkinson as independent Chairman of the Board and John J. May as an independent director, effective immediately.
Leadership changes can signal strategic shifts within a company, potentially affecting governance and operational direction, impacting investor confidence and stock performance.
Equus Announces Third Quarter Net Asset Value
2 months agoEquus Total Return, Inc. reported net assets of $40.2 million and a decrease in net asset value per share to $2.96 as of September 30, 2024, down from $3.66 on June 30, 2024.
The decline in net asset value per share from $3.66 to $2.96 signals a potential decrease in company value, impacting investor confidence and future investment decisions.
Equus Announces Second Quarter Net Asset Value
5 months agoEquus Total Return, Inc. reported net assets of $49.8 million as of June 30, 2024, with a net asset value per share increase to $3.66 from $3.38 as of March 31, 2024.
Equus Total Return's rising net asset value per share signals improved financial health, potentially attracting more investors and boosting share price.
Equus Announces First Quarter Net Asset Value
8 months agoEquus Total Return, Inc. reported net assets of $45.9 million as of March 31, 2024, with a net asset value per share of $3.38, down from $3.55 at year-end 2023.
A decline in net asset value per share indicates reduced financial health for Equus Total Return, potentially impacting investor confidence and stock performance.
Equus Announces Fourth Quarter Net Asset Value
10 months agoEquus Total Return, Inc. (NYSE: EQS) reported net assets of $48.3 million and an increase in net asset value per share to $3.55 as of December 31, 2023, up from $3.49 in Q3 2023.
Equus Total Return's increased net asset value per share indicates improved financial health, which could attract investors seeking growth and stability in their portfolios.
Equus Subsidiary Morgan E&P Provides Update on Reserves
11 months agoEquus Total Return, Inc. (NYSE: EQS) reported an updated reserve estimate for its subsidiary Morgan E&P, which increased its acreage in the Bakken formation by 25.9%, from 4,747.52 to 5,976.84 net acres.
The updated reserve estimate and acreage increase in the Bakken/Three Forks formation could enhance Equus Total Return's asset value, impacting stock performance and investor sentiment positively.
Frequently Asked Questions About EQS Stock
What is Equus Total Return Inc's (EQS) stock forecast for 2025?
Analyst forecasts for Equus Total Return Inc (EQS) are not currently available. The stock is trading at $1.32.
Is EQS stock a good investment in 2025?
Analyst ratings for EQS are not currently available. The stock is currently trading at $1.32. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for EQS stock?
Price predictions from Wall Street analysts for EQS are not currently available. The stock is trading at $1.32.
What is Equus Total Return Inc's business model?
The company operates as a business development company (BDC), making money by investing in a variety of financial instruments including equity, debt, and preferred stock in small to mid-sized companies. It targets investments typically ranging from $1 million to $25 million in companies with revenues between $5 million and $150 million, and EBITDA between $2 million to $50 million. By acting as a lead investor, it focuses on leveraged buyouts, management buyouts, and operational turnarounds, among other strategies.
What is the highest forecasted price for EQS Equus Total Return Inc?
Price targets from Wall Street analysts for EQS are not currently available. The stock is trading at $1.32.
What is the lowest forecasted price for EQS Equus Total Return Inc?
Price targets from Wall Street analysts for EQS are not currently available. The stock is trading at $1.32.
What is the overall EQS consensus from analysts for Equus Total Return Inc?
Analyst ratings for EQS are not currently available. The stock is trading at $1.32.
How accurate are EQS stock price projections?
Stock price projections, including those for Equus Total Return Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
